Piramal Pharma Sees Surge in Open Interest Amidst Stock Performance Challenges
Piramal Pharma Ltd has seen a notable rise in open interest, reaching 1,332 contracts, alongside a trading volume of 626 contracts, indicating active market engagement. However, the stock has underperformed its sector and is currently trading below key moving averages, reflecting ongoing performance challenges.
Piramal Pharma Ltd, a prominent player in the Pharmaceuticals and Biotechnology sector, has experienced a significant increase in open interest today. The latest open interest stands at 1,332 contracts, reflecting a rise of 200 contracts or 17.67% from the previous open interest of 1,132. This uptick comes alongside a trading volume of 626 contracts, indicating active participation in the derivatives market.Despite this surge in open interest, Piramal Pharma's stock performance has been underwhelming, underperforming its sector by 0.79%. The stock has faced consecutive declines over the past two days, with a total drop of 1.15% during this period. Currently, Piramal Pharma is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend.
Additionally, the stock's delivery volume has decreased by 19.48% compared to its 5-day average, indicating a decline in investor participation. With a market capitalization of Rs 27,096.72 crore, Piramal Pharma remains a large-cap entity in the market. Overall, the notable increase in open interest highlights a shift in market dynamics, even as the stock grapples with recent performance challenges.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
